T147	ZeroArticleNP 0 10	Drug Label
T148	ZeroArticleNP 15 34	drug brand Betapace
T149	PossessivePronoun 214 236	their maintenance dose
T150	DefiniteNP 87 95	the risk
T151	IndefiniteNP 186 195	a minimum
T152	IndefiniteNP 241 251	a facility
T153	DefiniteNP 565 580	the maintenance
T154	DefiniteNP 775 801	the brand name Betapace AF
T155	DefiniteNP 832 855	the AFIB/AFL indication
T156	IndefiniteNP 947 971	a patient package insert
T157	IndefiniteNP 1188 1211	a functioning pacemaker
T158	DefiniteNP 1403 1421	The National Heart
T159	IndefiniteNP 1503 1548	a long-term, multi-center, double-blind study
T160	PossessivePronoun 1913 1935	their index infarction
T161	DefiniteNP 1803 1843	The Cardiac Arrhythmia Suppression Trial
T162	DefiniteNP 1882 1904	the recruited patients
T163	PersonalPronoun 2130 2131	I
T164	IndefiniteNP 2155 2183	an average time-on-treatment
T165	IndefiniteNP 2233 2261	an average time-on-treatment
T166	IndefiniteNP 2310 2336	all three active therapies
T167	DefiniteNP 2508 2538	The longer-term mortality rate
T168	DefiniteNP 2652 2669	The applicability
T169	IndefiniteNP 2690 2707	other populations
T170	DemonstrativeNP 2673 2686	these results
T171	ZeroArticleNP 2777 2806	Class I antiarrhythmic agents
T172	IndefiniteNP 2891 2925	a large (n=1,456) controlled trial
T173	IndefiniteNP 2943 2973	a recent myocardial infarction
T174	ZeroArticleNP 2867 2882	Class I effects
T175	DefiniteNP 3128 3142	the other hand
T176	DefiniteNP 3147 3177	the large postinfarction study
T177	IndefiniteNP 3184 3211	a non-titrated initial dose
T178	IndefiniteNP 3240 3271	a second small randomized trial
T179	IndefiniteNP 3379 3388	an excess
T180	IndefiniteNP 3434 3461	other antiarrhythmic agents
T181	IndefiniteNP 3527 3540	some patients
T182	PossessivePronoun 3663 3673	its effect
T183	DefiniteNP 3808 3823	the QT interval
T184	DefiniteNP 3858 3878	the most common form
T185	IndefiniteNP 3749 3786	a polymorphic ventricular tachycardia
T186	IndefiniteNP 3828 3854	a shifting electrical axis
T187	DefiniteNP 3996 4004	The risk
T188	DefiniteNP 4072 4087	the QT interval
T189	PersonalPronoun 4262 4264	it
T190	DefiniteNP 4213 4245	the variable temporal recurrence
T191	DefiniteNP 4352 4363	the patient
T192	IndefiniteNP 4311 4347	a new or aggravated arrhythmic event
T193	DefiniteNP 4518 4531	the incidence
T194	DefiniteNP 4595 4615	the occurrence rates
T195	IndefiniteNP 4445 4470	a drug-induced arrhythmia
T196	IndefiniteNP 4486 4509	an initially normal QTc
T197	PersonalPronoun 4745 4749	they
T198	DefiniteNP 4776 4784	the drug
T199	PersonalPronoun 4819 4821	It
T200	DefiniteNP 4836 4858	the NIH-sponsored CAST
T201	IndefiniteNP 4891 4916	some antiarrhythmic drugs
T202	IndefiniteNP 5065 5091	a sustained increased risk
T203	IndefiniteNP 5168 5173	a new
T204	DemonstrativeNP 5213 5222	this 4.3%
T205	DemonstrativeNP 5441 5451	such cases
T206	DefiniteNP 5602 5615	the incidence
T207	DefiniteNP 5770 5783	the incidence
T208	IndefiniteNP 5554 5563	a history
T209	DefiniteNP 5893 5909	the prolongation
T210	DefiniteNP 5944 5959	the table below
T211	DefiniteNP 6125 6141	the QTc interval
T212	IndefiniteNP 6011 6029	other risk factors
T213	IndefiniteNP 6078 6096	a higher incidence
T214	DefiniteNP 6322 6338	the highest risk
T215	IndefiniteNP 6269 6278	a history
T216	PossessivePronoun 6471 6492	their baseline rhythm
T217	DefiniteNP 6374 6386	the patients
T218	DefiniteNP 6494 6504	The others
T219	IndefiniteNP 6596 6607	other drugs
T220	PersonalPronoun 6627 6629	It
T221	IndefiniteNP 6667 6685	some sudden deaths
T222	IndefiniteNP 6737 6751	some instances
T223	IndefiniteNP 6776 6796	a documented episode
T224	IndefiniteNP 6935 6947	a lower dose
T225	ZeroArticleNP 6829 6845	Betapace therapy
T226	DefiniteNP 7013 7020	the QTc
T227	DefiniteNP 7111 7119	the dose
T228	DefiniteNP 7150 7157	the QTc
T229	ZeroArticleNP 7137 7144	therapy
T230	DefiniteNP 7183 7208	the multiple risk factors
T231	DefiniteNP 7296 7312	the QTc interval
T232	DefiniteNP 7314 7329	The table below
T233	DefiniteNP 7338 7351	the incidence
T234	PersonalPronoun 7424 7426	It
T235	DefiniteNP 7458 7487	the highest on-therapy QTcwas
T236	DefiniteNP 7502 7509	the one
T237	DefiniteNP 7522 7530	the time
T238	DefiniteNP 7534 7562	the Torsade de Pointes event
T239	DefiniteNP 7572 7581	the table
T240	DefiniteNP 7593 7613	the predictive value
T241	IndefiniteNP 7617 7627	a high QTc
T242	ZeroArticleNP 7693 7700	therapy
T243	IndefiniteNP 7821 7832	an increase
T244	IndefiniteNP 8029 8044	a dosage change
T245	DemonstrativeNP 7977 7988	such events
T246	ZeroArticleNP 7807 7814	therapy
T247	ZeroArticleNP 7946 7962	Betapace therapy
T248	DefiniteNP 8276 8284	the risk
T249	ZeroArticleNP 8046 8064	Initiating therapy
T250	DefiniteNP 8440 8448	the risk
T251	DefiniteNP 8654 8674	the potential hazard
T252	ZeroArticleNP 8838 8847	diuretics
T253	IndefiniteNP 8948 8965	all beta-blockers
T254	IndefiniteNP 9027 9039	any evidence
T255	ZeroArticleNP 9002 9009	therapy
T256	DefiniteNP 9262 9275	The incidence
T257	IndefiniteNP 9381 9396	a prior history
T258	DefiniteNP 9460 9482	the one-year incidence
T259	IndefiniteNP 9438 9458	a lifetable analysis
T260	IndefiniteNP 9533 9548	a prior history
T261	IndefiniteNP 9574 9589	a prior history
T262	DefiniteNP 9649 9662	the incidence
T263	ZeroArticleNP 9730 9757	1395 Class I patients, 4.9%
T264	ZeroArticleNP 9761 9774	1254 Class II
T265	ZeroArticleNP 9796 9805	278 Class
T266	DefiniteNP 9999 10009	the degree
T267	DefiniteNP 10043 10056	the potential
T268	DemonstrativeNP 9967 9983	these conditions
T269	ZeroArticleNP 10228 10254	concomitant diuretic drugs
T270	DefiniteNP 10308 10323	the QT interval
T271	PersonalPronoun 10596 10602	itself
T272	DefiniteNP 10613 10621	the risk
T273	DefiniteNP 10733 10746	The incidence
T274	DefiniteNP 10864 10887	the long-term treatment
T275	IndefiniteNP 10942 10965	a myocardial infarction
T276	DefiniteNP 10990 10997	the use
T277	DefiniteNP 11042 11057	the early phase
T278	DefiniteNP 11178 11195	the first 2 weeks
T279	DefiniteNP 11345 11367	The following warnings
T280	DefiniteNP 11383 11409	the beta-blocking activity
T281	ZeroArticleNP 11523 11543	beta-blocker therapy
T282	IndefiniteNP 11618 11628	some cases
T283	ZeroArticleNP 11703 11723	beta-blocker therapy
T284	PersonalPronoun 11736 11738	it
T285	DefiniteNP 11879 11890	the patient
T286	DefiniteNP 11904 11921	the temporary use
T287	IndefiniteNP 11925 11964	an alternate betablocker if appropriate
T288	DefiniteNP 11979 11989	the dosage
T289	IndefiniteNP 12035 12043	a period
T290	ZeroArticleNP 12117 12136	appropriate therapy
T291	DefiniteNP 12253 12266	the physician
T292	ZeroArticleNP 12237 12244	therapy
T293	PersonalPronoun 12621 12623	It
T294	DefiniteNP 12702 12729	the smallest effective dose
T295	IndefiniteNP 12925 12934	a history
T296	IndefiniteNP 12963 12972	a variety
T297	IndefiniteNP 12995 13017	a more severe reaction
T298	DefiniteNP 13124 13139	the usual doses
T299	DefiniteNP 13169 13190	the allergic reaction
T300	DemonstrativeNP 13087 13100	Such patients
T301	DefiniteNP 13321 13341	the impaired ability
T302	DefiniteNP 13345 13354	the heart
T303	DefiniteNP 13407 13416	the risks
T304	ZeroArticleNP 13233 13254	beta-blocking therapy
T305	IndefiniteNP 13538 13547	a history
T306	IndefiniteNP 13656 13729	some important premonitory signs of acute hypoglycemia, e.g., tachycardia
T307	PersonalPronoun 13889 13891	it
T308	IndefiniteNP 14201 14216	an exacerbation
T309	DefiniteNP 14367 14378	the kidneys
T310	IndefiniteNP 14416 14430	a small degree
T311	DefiniteNP 14569 14589	the elimination rate
T312	IndefiniteNP 14462 14483	a direct relationship
T313	ZeroArticleNP 14724 14729	Drugs
T314	DefiniteNP 14886 14906	the pharmacokinetics
T315	ZeroArticleNP 14823 14828	drugs
T316	PersonalPronoun 14995 14997	it
T317	DefiniteNP 15023 15029	the PK
T318	IndefiniteNP 14964 14982	any CYP450 enzymes
T319	DemonstrativeNP 15063 15076	these enzymes
T320	ZeroArticleNP 15033 15038	drugs
T321	PossessivePronoun 15290 15305	their potential
T322	IndefiniteNP 15180 15201	other Class III drugs
T323	ZeroArticleNP 15096 15125	Class Ia antiarrhythmic drugs
T324	ZeroArticleNP 15244 15263	concomitant therapy
T325	DefiniteNP 15387 15406	the concomitant use
T326	ZeroArticleNP 15410 15418	Class Ib
T327	ZeroArticleNP 15422 15440	Ic antiarrhythmics
T328	DefiniteNP 15499 15506	the use
T329	IndefiniteNP 15510 15536	other beta-blocking agents
T330	ZeroArticleNP 15442 15459	Additive Class II
T331	PersonalPronoun 15755 15757	it
T332	DefiniteNP 15827 15839	the presence
T333	DefiniteNP 15890 15902	the patients
T334	IndefiniteNP 15795 15809	an interaction
T335	IndefiniteNP 15848 15867	a known risk factor
T336	DefiniteNP 16053 16061	the risk
T337	ZeroArticleNP 16168 16190	calcium-blocking drugs
T338	DemonstrativeNP 16317 16328	these drugs
T339	IndefiniteNP 16531 16545	a beta-blocker
T340	IndefiniteNP 16558 16580	an excessive reduction
T341	ZeroArticleNP 16459 16488	catecholamine-depleting drugs
T342	IndefiniteNP 16654 16678	a catecholamine depletor
T343	DefiniteNP 16860 16870	the dosage
T344	ZeroArticleNP 16898 16903	drugs
T345	DefiniteNP 17195 17219	the rebound hypertension
T346	ZeroArticleNP 17160 17179	Beta-blocking drugs
T347	PersonalPronoun 17599 17601	it
T348	DefiniteNP 17712 17734	the bradycardic effect
T349	IndefiniteNP 17616 17627	a reduction
T350	IndefiniteNP 17693 17708	a 25% reduction
T351	DefiniteNP 17762 17773	the antacid
T352	DefiniteNP 17816 17836	the pharmacokinetics
T353	DefiniteNP 17887 17902	the QT interval
T354	ZeroArticleNP 17870 17875	Drugs
T355	IndefiniteNP 17969 18013	other drugs known to prolong the QT interval
T356	ZeroArticleNP 18022 18029;18044 18065	Class I antiarrhythmic agents
T357	ZeroArticleNP 18034 18065	Class III antiarrhythmic agents
T358	DefiniteNP 18244 18256	The presence
T359	DefiniteNP 18271 18280	the urine
T360	IndefiniteNP 18439 18457	a pheochromocytoma
T361	IndefiniteNP 18490 18507	a specific method
T362	IndefiniteNP 18517 18564	a high performance liquid chromatographic assay
T363	DefiniteNP 18940 18948	the MRHD
T364	DefiniteNP 19081 19089	the MRHD
T365	IndefiniteNP 18811 18827	a 24-month study
T366	IndefiniteNP 18978 18994	a 24-month study
T367	IndefiniteNP 19135 19153	any specific assay
T368	DefiniteNP 19399 19409	the number
T369	IndefiniteNP 19378 19395	a small reduction
T370	DefiniteNP 19540 19548	the MRHD
T371	DefiniteNP 19573 19581	the MRHD
T372	IndefiniteNP 19622 19647	any teratogenic potential
T373	IndefiniteNP 19689 19700	a high dose
T374	IndefiniteNP 19799 19816	a slight increase
T375	DefiniteNP 19877 19893	the maximum dose
T376	DefiniteNP 19919 19927	the MRHD
T377	IndefiniteNP 19956 19978	an increased incidence
T378	DefiniteNP 20092 20102	the number
T379	DefiniteNP 20431 20443	the placenta
T380	IndefiniteNP 20492 20500	a report
T381	DefiniteNP 20602 20623	the potential benefit
T382	DefiniteNP 20634 20652	the potential risk
T383	DefiniteNP 20695 20703	the milk
T384	DefiniteNP 20788 20801	the potential
T385	DefiniteNP 20933 20941	the drug
T386	DefiniteNP 20963 20977	the importance
T387	DefiniteNP 20981 20989	the drug
T388	DefiniteNP 20993 21003	the mother
T389	IndefiniteNP 20858 20868	a decision
T390	DefiniteNP 21021 21031	The safety
T391	DefiniteNP 21170 21190	the pharmacokinetics
T392	DefiniteNP 21196 21212	the relationship
T393	DefiniteNP 21221 21232	the effects
T394	ZeroArticleNP 21114 21142	Class III electrophysiologic
T395	ZeroArticleNP 21275 21294	drug concentrations
T2	Drug 8849 8857	Betapace
T4	Drug 8821 8830	digitalis
T5	Drug_Class 8838 8847	diuretics
T7	Drug_Class 10240 10254	diuretic drugs
T8	Drug_Class 15096 15125	Class Ia antiarrhythmic drugs
T9	Drug 15135 15147	disopyramide
T10	Drug 15149 15158	quinidine
T11	Drug 15163 15175	procainamide
T12	Drug_Class 15186 15201	Class III drugs
T13	Drug 15209 15219	amiodarone
T15	Drug 15269 15277	Betapace
T19	Drug_Class 15451 15459	Class II
T20	Drug 15556 15564	Betapace
T22	Drug 15705 15713	Betapace
T23	Drug 15746 15753	digoxin
T25	Drug_Class 15927 15947	digitalis glycosides
T26	Drug_Class 15952 15965	beta-blockers
T28	Drug 16103 16111	Betapace
T29	Drug_Class 16168 16190	calcium-blocking drugs
T34	Drug_Class 16459 16488	catecholamine-depleting drugs
T35	Drug 16498 16507	reserpine
T36	Drug 16512 16524	guanethidine
T37	Drug_Class 16533 16545	beta-blocker
T39	Drug 16640 16648	Betapace
T40	Drug_Class 16656 16678	catecholamine depletor
T44	Drug 16874 16881	insulin
T46	Drug_Class 16811 16829	oral antidiabetics
T50	Drug_Class 16969 16995	Beta-2-receptor stimulants
T51	Drug 17019 17029	salbutamol
T52	Drug 17031 17042	terbutaline
T53	Drug 17047 17059	isoprenaline
T55	Drug 17138 17146	Betapace
T56	Drug 17487 17495	Betapace
T57	Drug_Class 17514 17572	antacids containing aluminum oxide and magnesium hydroxide
T62	Drug 17904 17912	Betapace
T63	Drug_Class 17975 18013	drugs known to prolong the QT interval
T64	Drug_Class 18022 18029;18044 18065	Class I antiarrhythmic agents
T65	Drug_Class 18034 18065	Class III antiarrhythmic agents
T66	Drug_Class 18067 18081	phenothiazines
T67	Drug_Class 18083 18108	tricyclic antidepressants
T68	Drug 18110 18120	astemizole
T69	Drug 18122 18130	bepridil
T70	Drug_Class 18140 18155	oral macrolides
T71	Drug_Class 18169 18190	quinolone antibiotics
T72	Drug_Class 2777 2806	Class I antiarrhythmic agents
T73	Drug_Class 4896 4916	antiarrhythmic drugs
T74	Drug_Class 16079 16101	Calcium-blocking drugs
T75	Drug_Class 9766 9774	Class II
T76	Drug 15567 15574	Digoxin
T77	Drug 15648 15655	digoxin
T78	Drug 15913 15920	digoxin
T79	Drug 17149 17158	Clonidine
T80	Drug 17264 17273	clonidine
T81	Drug 17324 17333	clonidine
T82	Drug_Class 8952 8965	beta-blockers
T83	Drug_Class 12606 12619	BETA-BLOCKERS
T84	Drug_Class 12896 12909	beta-blockers
T85	Drug 8898 8907	digitalis
T86	Drug 1776 1786	flecainide
T87	Drug 2420 2430	flecainide
T88	Drug 26 34	Betapace
T89	Drug 156 164	Betapace
T90	Drug 790 798	Betapace
T91	Drug 803 811	Betapace
T92	Drug 890 898	Betapace
T93	Drug 915 923	Betapace
T94	Drug 1041 1049	Betapace
T95	Drug 1369 1377	Betapace
T96	Drug 2821 2829	Betapace
T97	Drug 3029 3037	Betapace
T98	Drug 3463 3471	Betapace
T99	Drug 3912 3920	Betapace
T100	Drug 6829 6837	Betapace
T101	Drug 6962 6970	Betapace
T102	Drug 7946 7954	Betapace
T103	Drug 9252 9260	Betapace
T104	Drug 9712 9720	Betapace
T105	Drug 9855 9863	Betapace
T106	Drug 10503 10511	Betapace
T107	Drug 10817 10825	Betapace
T108	Drug 11001 11009	Betapace
T109	Drug 11413 11421	Betapace
T110	Drug 11794 11802	Betapace
T111	Drug 11993 12001	Betapace
T112	Drug 12365 12373	Betapace
T113	Drug 12639 12647	Betapace
T114	Drug 13589 13597	Betapace
T115	Drug 13753 13761	Betapace
T116	Drug 14308 14316	Betapace
T117	Drug 14593 14601	Betapace
T118	Drug 15605 15613	Betapace
T119	Drug 17356 17364	Betapace
T120	Drug 17790 17798	Betapace
T121	Drug 20532 20540	Betapace
T122	Drug 20553 20561	Betapace
T123	Drug 20848 20856	Betapace
T124	Drug 21053 21061	Betapace
T125	Drug 16799 16806	Insulin
T126	Drug 17448 17456	warfarin
T127	Drug 17425 17444	hydrochlorothiazide
T128	Drug_Class 11523 11535	beta-blocker
T129	Drug_Class 11703 11715	beta-blocker
T130	Drug 13143 13154	epinephrine
T131	Drug 1765 1774	encainide
T132	Drug 2406 2415	encainide
T133	Drug 5446 5451	cases
T134	Drug 7496 7501	cases
T135	Drug 11556 11561	cases
T136	Drug 11623 11628	cases
T3	Drug 1791 1801	moricizine
T24	Drug 14919 14926	Sotalol
T30	Substance 14968 14982	CYP450 enzymes
T396	SPAN 199 209	three days
T397	SPAN 4675 4699	drug-induced arrhythmias
T398	SPAN 6420 6444	approximately two-thirds
T399	SPAN 10584 10595	Bradycardia
T400	SPAN 11443 11459	Hypersensitivity
T401	SPAN 13820 13839	sick sinus syndrome
T402	SPAN 17469 17483	Administration
T403	SPAN 3729 3747	Torsade de Pointes
R18	Appositive Attribute:T357 Head:T66
R19	Appositive Attribute:T357 Head:T71
R20	Appositive Attribute:T357 Head:T69
R21	Appositive Attribute:T357 Head:T67
R22	Appositive Attribute:T357 Head:T68
R23	Appositive Attribute:T357 Head:T70
R24	Anaphora Anaphor:T198 Antecedent:T99
R25	Anaphora Anaphor:T319 Antecedent:T320
R26	Anaphora Anaphor:T321 Antecedent:T8
R27	Anaphora Anaphor:T338 Antecedent:T29
R28	Anaphora Anaphor:T385 Antecedent:T123
R29	Anaphora Anaphor:T387 Antecedent:T385
